Global Digital Therapeutics Market 2022 - Snapshot
This industry report offers market estimates of the global market, followed by a detailed analysis of the application, end user, and region. The global market data on digital therapeutics can be segmented By applicationt: cardiovascular diseases (CVD), central nervous system (CNS) diseases, diabetes, obesity, respiratory diseases, smoking cessation, others. Digital therapeutics market is further segmented By end user:employers, patients, payers, providers, others. Based on region, the digital therapeutics market is segmented into: North America, Europe, Asia-Pacific, Rest of the World.
The global digital therapeutics market is highly competitive. Some of the leading companies operating in the market are 2Morrow Inc., Canary Health Inc., FITBIT Inc., NOOM INC., Omada Health Inc., Pear Therapeutics Inc., Propeller Health (ResMed Inc.), Teladoc Health Inc., TrialCard Incorporated, Twill Inc., Welldoc Inc.
The data-centric report focuses on market trends, status and outlook for segments. With comprehensive market assessment across the major geographies, the report is a valuable asset for the existing players, new entrants and the future investors.
Why buy this report?
- Get a detailed picture of the Global Digital Therapeutics Market
- Identify segments/areas to invest in over the forecast period in the Global Digital Therapeutics Market
- Understand the competitive environment, the markets leading players
- The market estimate for ease of analysis across scenarios in Excel format.
- Strategy consulting and research support for three months.
- Print authentication provided for the single-user license.
Part 2. Introduction
Study period
Geographical scope
Market segmentation
Part 3. Digital therapeutics market overview
Part 4. Market breakdown by application
Cardiovascular diseases (CVD)
Central nervous system (CNS) diseases
Diabetes
Obesity
Respiratory diseases
Smoking cessation
Others
Part 5. Market breakdown by end user
Employers
Patients
Payers
Providers
Others
Part 6. Market breakdown by region
North America
Europe
Asia-Pacific
Rest of the World
Part 7. Key companies
2Morrow, Inc.
Canary Health, Inc.
FITBIT, Inc.
NOOM, INC.
Omada Health, Inc.
Pear Therapeutics, Inc.
Propeller Health (ResMed Inc.)
Teladoc Health, Inc.
TrialCard Incorporated
Twill Inc.
Welldoc, Inc.
Part 8. Methodology
2024 Global Hepatitis Diagnostic Testing Markers Supplier Shares and Strategies Volume and Sales Segment Forecasts for Immunodiagnostic and Molecular Diagnostic Procedures--Hospitals Blood Banks Commercial Labs POC Locations
2024 Global Hepatitis Diagnostic Testing for 10 Markers: Supplier Shares and Strategies, Volume and Sales Segment Forecasts for Immunodiagnostic and Molecular Diagnostic Procedures--Hospitals, Blood Banks, Commercial Labs, POC Locations The
USD 7500 View Report2024 Global PSA Testing Market Supplier Shares and Strategies Volume and Sales Segment Forecasts Emerging Opportunities
2024 Global PSA Testing Market: US, Europe, Japan--Supplier Shares and Strategies, Volume and Sales Segment Forecasts, Emerging Opportunities This unique report from provides information and analysis not available from any
USD 2450 View ReportGlobal Digital Light Processing (DLP) Projector Market 2023
DescriptionThe Digital Light Processing (DLP) Projector Market is poised for significant growth, with a projected increase from USD 4.83 billion in 2022 to USD 7.19 billion by 2029. This growth
USD 1950 View ReportGlobal Digital Health and Wellness Market 2023
The global digital health market was valued at USD 328.3 billion in 2022 and is forecast to reach USD 1,037 billion by 2029, reflecting a compound annual growth rate of
USD 3450 View ReportFill The Form For Sample Request